Condition
Blood Loss During Surgery
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07392034Phase 2Completed
Efficacy of Tranexamic Acid Reducing Blood Loss During Maxillofacial Trauma Surgery
NCT07013812Phase 4Completed
Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section
NCT01701960Withdrawn
Effect of Local Anesthetic on Hemodynamic Measures During Nasal Surgery
Showing all 3 trials